How will Google Life Sciences create its highly anticipated nanotech diagnostic hordes? Precision NanoSystems might know. It's nabbed a $13.4 million Series A round to back its NanoAssemblr platform that can be used to create next-gen nanoparticle therapeutic and diagnostic agents targeted to the cellular level.
San Francisco, CA-based CliniCloud plans to launch its first product, a connected medical kit including a stethoscope and non-contact thermometer, at consumer electronics outlet Best Buy in the U.S. and Canada before then.
The nonprofit Institute of Medicine called for improving the quality of medical diagnoses in its latest "quality chasm" series of reports. Diagnostic errors account for about 10% of patient deaths and adverse events.
The middle class in emerging market countries wants diagnostics--and Minneapolis, MN-based Ativa Medical plans to bring it to them via a point-of-care, micro lab designed for the physician office. The startup has secured a $15 million Series B round that's intended to support gaining FDA approval for its micro lab and preparing for commercial launch.
Scientists have discovered a new variant of graphene dubbed phagraphene, in which the electron velocity can be manipulated.
Hand-held vital sign monitor Scanadu has made a big splash with its Indiegogo crowdfunding campaign that was followed up by being selected as a finalist in the $10 million Qualcomm Tricorder Xprize competition last year. Now it's working to legitimize its Scanadu Scout wireless vital sign monitor in a massive trial of more than 4,000 people conducted by Scripps Translational Science Institute.
MediBeacon will nab $22.4 million via a staged financing from Pansend, which is a subsidiary of diversified holding company HC2 Holdings. The cash will go to bring its first product to market--a real-time, noninvasive kidney monitor.
Digital health player DynoSense expects to use its new $9.4 million Series A financing to gain FDA clearance for its hand-held scanner that grabs more than 33 health metrics, including commonly monitored vital signs, in under one minute. Dubbed the Dyno, the device captures the data and sends it to the cloud for analysis that is subsequently sent to healthcare providers.
A survey conducted by Abbott concludes that most adults do not recognize common concussion symptoms.
An international entrepreneurial trio has developed a hand-worn ring that detects syphilis, gonorrhea, chlamydia and trichomoniasis--wirelessly transmitting the results to a smartphone or tablet in under one minute. Known as Hoope, the device has a retractable needle and an anesthetic system based on electrical pulses; it is slated to debut on crowdfunding site Indiegogo in January.